TEAS Combined With Triple Antiemetic Drugs to Prevent PONV in High-Risk Patients
Zhejiang University
Zhejiang University
Medtronic - MITG
Lo.Li.Pharma s.r.l
Virtual Tribunal Monastery
University of California, San Francisco
Cangzhou Central Hospital
Qilu Pharmaceutical Co., Ltd.
JW Pharmaceutical
Alexandria University
Johns Hopkins University
Sumitomo Pharma Switzerland GmbH
University of Miami
University of California, Los Angeles
Yuri Semenyuk Rivne Regional Clinical Hospital
Endeavor Health
Kissei Pharmaceutical Co., Ltd.
Assistance Publique - Hôpitaux de Paris
Institut Bergonié
Acessa Health, Inc.
University of Chicago
West China Second University Hospital
University Hospital, Geneva
Zenchi, Inc.
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Jiangsu HengRui Medicine Co., Ltd.
Sumitomo Pharma Switzerland GmbH
University Hospitals Cleveland Medical Center
Washington University School of Medicine
University of Faisalabad
Bayer
Yale University
AbbVie
Maaynei Hayesha Medical Center
Massachusetts General Hospital
Thomas Jefferson University
Second Affiliated Hospital of Wenzhou Medical University
Kissei Pharmaceutical Co., Ltd.
Universita di Verona
Assistance Publique Hopitaux De Marseille
Chinese University of Hong Kong
Krankenhaus Nordwest
University of Texas Southwestern Medical Center
Wake Forest University Health Sciences
Bayer
Kaohsiung Medical University
Northwestern University
Assistance Publique Hopitaux De Marseille
University of California, Irvine
National Institutes of Health Clinical Center (CC)
Sunnybrook Health Sciences Centre